Stock listing
NASDAQ:TPTX Turning Point Therapeutics Inc Stock
Follow Turning Point Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:TPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TPTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Turning Point Therapeutics Inc on 6ix
- Calls
- 4 calls with a replay · 4 with a transcript · latest Aug 9, 2021
- Decks
- 8 decks · latest May 10, 2022
Events
| Call | When | Status |
|---|---|---|
| Turning Point Therapeutics (TPTX) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 4:30 PM ET | Replay |
| Turning Point Therapeutics (TPTX) Q3 2021 Earnings Call | Mon, Aug 09, 2021 · 4:30 PM ET | Replay |
| Turning Point Therapeutics (TPTX) Q1 2021 Earnings Call | Wed, May 05, 2021 · 5:00 PM ET | Replay |
| Turning Point Therapeutics (TPTX) Q4 2020 Earnings Call | Mon, Mar 01, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2022) | Investor deck | 53 slides | May 10, 2022 |
| Technical Presentation (April 2022) | Technical | 15 slides | Apr 13, 2022 |
| Investor Presentation (October 2021) | Investor deck | 46 slides | Oct 8, 2021 |
| AACR-NCI-EORTC Investor Meeting 2021 | Conference | 29 slides | Oct 7, 2021 |
| Investor Presentation (January 2021) | Investor deck | 33 slides | Jan 11, 2021 |
| Investor Presentation (October 2020) | Investor deck | 30 slides | Oct 26, 2020 |
| Technical Presentation (August 2020) | Technical | 17 slides | Aug 19, 2020 |
| 38th Annual J.P. Morgan Healthcare Conference (January 2020) | Conference | 21 slides | Jan 13, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · May 13, 2019 – Aug 17, 2022 · Past |
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past) | Director · Jul 24, 2019 – Aug 17, 2022 · Past |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Jun 2, 2021 – Aug 17, 2022 · Past |
| Simeon George Other companies: ADARx Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2026); Design Therapeutics, Inc. (Director · Since at least Jun 15, 2022); CRISPR Therapeutics AG (Director · Since at least Jun 9, 2022); Nkarta, Inc. (Director · Since at least Apr 28, 2022) | Director · Aug 17, 2022 – Aug 17, 2022 · Past |
| Mark J Alles Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past); Celgene Corporation (CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past) | Director · May 24, 2021 – Aug 17, 2022 · Past |
| Mohammad Hirmand Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Medivation Inc (Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past) | EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past |
| Yi Larson Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2021); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past) | EVP & Chief Financial Officer · Aug 26, 2019 – Feb 8, 2021 · Past |
| Steve M Sabus Other companies: Syndax Pharmaceuticals, Inc. (Chief Commercial Officer · Dec 5, 2022 – Dec 5, 2022 · Past) | SVP & Chief Commercial Officer · May 31, 2022 – Aug 17, 2022 · Past |
| Annette North | EVP & General Counsel · Apr 16, 2019 – Feb 9, 2022 · Past |
| Brian Sun | SVP & General Counsel · Apr 11, 2022 – Aug 17, 2022 · Past |
All 12 people
| Person | Seat |
|---|---|
| Paolo Tombesi | EVP & Chief Financial Officer · Jul 27, 2022 – Aug 17, 2022 · Past |
| Siegfried Reich | EVP & Chief Scientific Officer · Feb 8, 2021 – Feb 9, 2022 · Past |
Log in to ask 6ix AI your own questions about Turning Point Therapeutics Inc.